Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc

22
2
NAS:REGN (USA)   Ordinary Shares
$ 1051.10 +6.705 (+0.64%) 10:46 AM EST
31.05
P/B:
4.29
Market Cap:
$ 115.82B
Enterprise V:
$ 107.14B
Volume:
239.63K
Avg Vol (2M):
421.85K
Trade In:
Volume:
239.63K
Avg Vol (2M):
421.85K

Business Description

Description
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).

Financials (Next Earnings Date:2024-08-02 Est.)

REGN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:REGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Regeneron Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 13,100.1
EPS (TTM) ($) 33.85
Beta 0.48
Volatility % 20.52
14-Day RSI 73.32
14-Day ATR ($) 16.346177
20-Day SMA ($) 1006.1565
12-1 Month Momentum % 26.38
52-Week Range ($) 684.805 - 1052.7999
Shares Outstanding (Mil) 110.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regeneron Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Regeneron Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Regeneron Pharmaceuticals Inc Frequently Asked Questions

What is Regeneron Pharmaceuticals Inc(REGN)'s stock price today?
The current price of REGN is $1051.10. The 52 week high of REGN is $1052.80 and 52 week low is $684.81.
When is next earnings date of Regeneron Pharmaceuticals Inc(REGN)?
The next earnings date of Regeneron Pharmaceuticals Inc(REGN) is 2024-08-02 Est..
Does Regeneron Pharmaceuticals Inc(REGN) pay dividends? If so, how much?
Regeneron Pharmaceuticals Inc(REGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1